🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Improving diagnosis of lung conditions is an Asthma + Lung UK Research priority. Great to see promising work to simplify diagnosis of ILDs using exhaled breath. Co-authored by Asthma + Lung UK Chair Phil Molyneaux #ERSCongress

Pirfenidone for IPD pts undergoing surgery for NSCLC RP3 trial. N=232. IPF AEs reduced by P 6.1 vs 10.3 non sign. Risk score re-evaluation rabies reduction on AEs 3.2 cs 15.5cases. Overall, a negative trial. #ESMO24 ESMO - Eur. Oncology

Wow! Boehringer-Ingelheim announces that Nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study - a decade after the first positive phase III trials for IPF. Cannot wait to see the full results but this EXCITING !!! #CureIPF boehringer-ingelheim.com/us/topline-res…

🔥🔥Mirtazapine should not be recommended as a routine treatment for severe breathlessness in patients with COPD or interstitial lung diseases. 📊 #KeyFindings Mirtazapine 🟰 Placebo in reducing severe breathlessness. ✅ Randomized, double-blind design ⚠️ High variability in

Low dose morphine could treat chronic cough in people with idiopathic pulmonary fibrosis, a condition where the lungs become scarred and breathing becomes more difficult. The PACIFY COUGH study took place at Manchester CRF Wythenshawe Hospital. Read more 👇 manchestercrf.nihr.ac.uk/low-dose-morph…

Join our dynamic, research active ILD team at Wythenshawe Hospital (Manchester University NHS Foundation Trust). Locum consultant initially….substantive post to follow… eur01.safelinks.protection.outlook.com/?url=http%3A%2…

Cough in Fibrotic Interstitial Lung Disease: Effects and Implications American Thoracic Society (ATS) 🔓 Open Access 🔗 tinyurl.com/3vw45f4k

Update from Symposium day two: it’s just as epic as the first 💪 While we’re all aware of visible skin and wound scarring, hidden scarring in internal organs is just as problematic. Today we welcomed researchers working in fibrosis - collaboration is key!

Interesting PhD studentship with Kate Randall at Northumbria Uni looking at the soil microbiome of allotments. If your interested in soil microbiomes please get in contact with Kate. tinyurl.com/ya347rfw

Publication 📃! We explored the #lungmicrobiota of post-COVID patients with lung abnormalities. 🧫Read more here: publications.ersnet.org/content/erjor/… !! Phil Molyneaux NHLI Royal Brompton and Harefield Imperial NHS 💙

We found in 2 studies, metformin (cheap, available, oral) associated with 30% lower asthma attacks. Adding GLP-1 had 40% further effect. This was not from better glycaemic control or weight loss! Seen in T2 low & high asthma! @BoheeLEE4 Aziz Sheikh NHLI Asthma + Lung UK Research

Proud to support Phil Molyneaux with an Asthma + Lung UK Chair award - Brilliant talk at #BTSWinter2024 on role of bacteria in IPF. 👏🏻

We have announced £72m of funding to establish 14 new Commercial Research Delivery Centres across England. These exciting new centres will work with industry partners and other research delivery infrastructure to speed up commercial clinical research delivery and make it more

Come learn to study the lung microbiome at ATS 2025! Meet and learn from an all-star team of experts. San Francisco, May 16th.

A new systematic review summarizes the available cough monitoring systems for #ChronicCough. Great resource to learn about the various options & how to objectively count #cough episodes. Witjaksono et al. (2025) in ERS publications 👇 bit.ly/3Fm5Nx3

Fibrosis: cross-organ biology and pathways to development of innovative drugs nature.com/articles/s4157… This new Review highlights core pathways active in fibrotic conditions across organs, and proposes strategies to improve the translation of potential antifibrotic drugs

Good to have a test people with more severe breathlessness can do…

We are delighted to again be partnering with Asthma + Lung UK Research and British Association for Lung Research (BALR) to present two lecture awards at this year's Winter Meeting in recognition of the achievements of established respiratory researchers. Find out more about the awards 👉 brit-thoracic.uk/LectureAwards25

Fantastic news for all our patients with IPF who suffer with cough! An overall 43% reduction in cough counts, similar improvement in patient reported cough and benefits seen in 2 weeks. We look forward to the phase 3 study!

Excited to share our study that is online ThoraxBMJ examining clinical trajectories by ILD subtype and CT UIP pattern thorax.bmj.com/content/early/…